🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to users administering substances of uncertain source.

Some experts stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.

Service Response and Content Elimination

Based on TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The company stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of members, filled with photos of weight loss, positive testimonials and detailed instructions for preparing or injecting at home.

After minutes of entering one community, a vendor posted contact information, where most purchases occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.

Item Details and Costs

Inside these groups, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may subject users to possibly significant health risks”.